Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Wed, Apr 23, 2025 05:27 PM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

André O. Hudson

Interim Dean/Professor-College of Science, Rochester Institute of Technology
The major themes of research in the Hudson lab are vested in biochemistry and microbiology. More specifically, in the areas of amino acid metabolism, structural analyses of enzymes involved in amino acid and bacterial peptidoglycan metabolism that are putative targets for antibiotic development, and the isolation, identification and genomic characterization of plant-associated bacteria. Dr. Hudson has secured approximately $3 million in federal/state funded grants and contracts as PI and or CoPI from the NIH, NSF, Bayer Corporation, Sweetwater Energy and Natcore Technology. Dr. Hudson has published over 75 peer-reviewed articles.

Dr. Hudson is a highly respected and well liked teacher. His teaching contributions are substantial especially during the conversion to semesters when he rewrote all the courses he teaches. Dr. Hudson has mentored and engaged many students in research and has published in peer-reviewed journals with a number of them. Many of his students have gone to pursue further research at prestigious institutions.

Dr. Hudson joined the RIT faculty in 2008 following a post-doctoral fellowship at Rutgers University. He earned his B.S. (2000) in Biology from Virginia Union University, Richmond, VA., and his Ph.D. (2006) in Plant Biochemistry from Rutgers University.

Will we still have antibiotics in 50 years? We asked 7 global experts

Oct 16, 2023 09:10 am UTC| Health

Almost since antibiotics were first discovered, weve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance. The World Health Organization says were currently...

Lab-grown meat techniques aren't new – cell cultures are common tools in science, but bringing them up to scale to meet society's demand for meat will require further development

Jun 28, 2023 15:30 pm UTC| Science

You might be old enough to remember the famous Wheres the Beef? Wendys commercials. This question may be asked in a different context since U.S. regulators approved the sale of lab-grown chicken meat made from cultivated...

Economy

Trump Calms Markets with Assurances on Fed and Tariffs

President Trump has gone to reassure markets by indicating that he has no plans to remove Federal Reserve Chairman Jerome Powell from office, walking back previous criticisms. While he once referred to Powell as a major...

Oil Prices Climb as U.S. Sanctions Iran, Trump Eases Fed Pressure

Oil prices extended gains in early Asian trading Wednesday following fresh U.S. sanctions on Iran and a larger-than-expected drop in U.S. crude inventories. Market sentiment was also lifted after President Donald Trump...

Asian Markets Rally on Hopes of Eased U.S.-China Tariffs

Asian stocks surged on Wednesday, buoyed by Wall Street gains after U.S. President Donald Trump suggested potential reductions in trade tariffs against China. His remarks sparked investor optimism, despite lingering...

Thai Rice Exports at Risk Amid US Tariffs and India’s Market Return

Thailands rice industry is facing a double blow as U.S. President Donald Trumps tariff threats loom and India resumes rice exports, driving prices down. Daeng Donsingha, a 70-year-old Thai farmer, struggles to stay afloat...

South Korea Seeks Swift Resolution on U.S. Auto Tariffs Amid Export Decline

South Koreas Industry Minister Ahn Duk-geun announced that Seoul is pushing for a swift resolution to the 25% U.S. auto tariffs in upcoming trade talks in Washington. The high-level meeting comes after the U.S. implemented...

Politics

Kremlin Cites 'Nuances' in Ukraine Peace Talks as U.S. Mediation Wavers

The Kremlin stated Wednesday that peace talks over Ukraine still face significant challenges, with many nuances requiring resolution before any agreement can be reached. This follows the abrupt cancellation of U.S....

Peter Dutton Pledges Boost in Australia’s Defence Spending Ahead of Election

Australias opposition leader Peter Dutton has vowed to raise defence spending to 3% of GDP within a decade if elected, aiming to strengthen national security amid growing global tensions and pressure from the Trump...

Elon Musk Clarifies Role at DOGE as Tesla Faces Investor Concerns

Tesla Inc (NASDAQ:TSLA) CEO Elon Musk clarified Tuesday that he is not stepping down from the Department of Government Efficiency (DOGE), but is merely reducing his time commitment. Responding to a post on X, Musk stated,...

Trump’s Approval Hits New Low Amid Public Backlash Over Power Moves

U.S. President Donald Trumps approval rating has dropped to 42%, the lowest since his return to the White House, according to a recent Reuters/Ipsos poll. The decline reflects growing public concern over his efforts to...

Over 200 University Leaders Slam Trump Administration Over Political Interference

More than 200 presidents from U.S. colleges and universities, including Harvard, Princeton, and Columbia, have jointly denounced what they call unprecedented political interference by the Trump administration in higher...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

BMW to Integrate Chinese AI from DeepSeek in China-Made Vehicles

German automotive giant BMW (ETR:BMWG) announced it will begin integrating artificial intelligence (AI) developed by Chinese startup DeepSeek into its upcoming vehicle models in China starting later this year. The...

Tesla’s Optimus Robot Faces Delays Amid China’s Rare Earth Export Curbs

Tesla CEO Elon Musk revealed that production of the companys Optimus humanoid robot has been delayed due to Chinas new export restrictions on rare earth magnetscritical components in robotics and electric vehicles....

DOJ Targets Google’s AI-Driven Search Monopoly in Landmark Antitrust Trial

The U.S. Department of Justice has launched a historic antitrust case against Alphabets Google (NASDAQ: GOOGL), aiming to prevent the tech giant from leveraging its artificial intelligence products to strengthen its...

Amazon Pauses Some AWS Data Center Leases Amid AI Demand Slowdown

Amazon.com (NASDAQ:AMZN) has reportedly paused portions of its data center leasing negotiations for Amazon Web Services (AWS), signaling a potential slowdown in demand from major artificial intelligence (AI) clients,...

Nintendo Faces Tariff Hurdles Ahead of Switch 2 Launch

Nintendo is preparing to launch the highly anticipated Switch 2 on June 5, marking eight years since the original Switch debuted. The console, which sold over 150 million units globally, became a pandemic-era favorite....